David B. Page

5.6k total citations · 2 hit papers
60 papers, 3.3k citations indexed

About

David B. Page is a scholar working on Oncology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, David B. Page has authored 60 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Oncology, 28 papers in Immunology and 14 papers in Pulmonary and Respiratory Medicine. Recurrent topics in David B. Page's work include Cancer Immunotherapy and Biomarkers (42 papers), Immunotherapy and Immune Responses (23 papers) and CAR-T cell therapy research (14 papers). David B. Page is often cited by papers focused on Cancer Immunotherapy and Biomarkers (42 papers), Immunotherapy and Immune Responses (23 papers) and CAR-T cell therapy research (14 papers). David B. Page collaborates with scholars based in United States, Austria and Switzerland. David B. Page's co-authors include Jedd D. Wolchok, Jarushka Naidoo, Katja Schindler, Mario E. Lacouture, Michael A. Postow, Bob T. Li, Louise C. Connell, Michael A. Postow, James P. Allison and Margaret K. Callahan and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

David B. Page

59 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies

2015 1.2k citations Jarushka Naidoo, David B. Page et al. Annals of Oncology profile →
Immune Modulation in Cancer with Antibodies

2013 403 citations David B. Page, James P. Allison et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David B. Page United States	22	2.4k	1.3k	628	599	283	60	3.3k
Ajay V. Maker United States	30	3.0k 1.3×	1.8k 1.4×	600 1.0×	826 1.4×	292 1.0×	127	4.4k
Christine Mateus France	29	3.8k 1.6×	1.2k 1.0×	799 1.3×	1.3k 2.1×	152 0.5×	85	4.9k
Camillo Ribi Switzerland	22	1.4k 0.6×	898 0.7×	996 1.6×	366 0.6×	75 0.3×	111	3.3k
Qingzhu Jia China	21	971 0.4×	627 0.5×	551 0.9×	628 1.0×	418 1.5×	55	2.4k
Ming Zhang China	29	1.2k 0.5×	467 0.4×	588 0.9×	751 1.3×	466 1.6×	167	2.7k
Hans‐Joachim Stemmler Germany	27	2.0k 0.9×	404 0.3×	981 1.6×	433 0.7×	222 0.8×	97	3.4k
Katharina C. Kähler Germany	22	2.5k 1.1×	776 0.6×	444 0.7×	603 1.0×	63 0.2×	79	2.9k
Timothy L. Frankel United States	28	1.5k 0.6×	733 0.6×	557 0.9×	663 1.1×	407 1.4×	81	2.6k
Marijo Bilušić United States	22	1.2k 0.5×	889 0.7×	512 0.8×	471 0.8×	173 0.6×	113	2.0k
Yusuke Okuma Japan	24	1.6k 0.7×	293 0.2×	936 1.5×	549 0.9×	273 1.0×	186	2.5k

Countries citing papers authored by David B. Page

Since Specialization

Citations

This map shows the geographic impact of David B. Page's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David B. Page with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David B. Page more than expected).

Fields of papers citing papers by David B. Page

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David B. Page. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David B. Page. The network helps show where David B. Page may publish in the future.

Co-authorship network of co-authors of David B. Page

This figure shows the co-authorship network connecting the top 25 collaborators of David B. Page. A scholar is included among the top collaborators of David B. Page based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David B. Page. David B. Page is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Comen, Elizabeth, Sadna Budhu, Yuval Elhanati, et al.. (2024). Preoperative immune checkpoint inhibition and cryoablation in early-stage breast cancer. iScience. 27(2). 108880–108880. 5 indexed citations

Page, David B., Kathryn Beal, Stefanie N. Linch, et al.. (2022). Brain radiotherapy, tremelimumab-mediated CTLA-4-directed blockade +/− trastuzumab in patients with breast cancer brain metastases. npj Breast Cancer. 8(1). 50–50. 25 indexed citations

Pucilowska, Joanna, Shu‐Ching Chang, Isaac Kim, et al.. (2022). Changes in T-cell subsets and clonal repertoire during chemoimmunotherapy with pembrolizumab and paclitaxel or capecitabine for metastatic triple-negative breast cancer. Journal for ImmunoTherapy of Cancer. 10(1). e004033–e004033. 11 indexed citations

Kim, Isaac, Joanna Pucilowska, William L. Redmond, et al.. (2021). Multiplex immunofluorescence to measure dynamic changes in tumor-infiltrating lymphocytes and PD-L1 in early-stage breast cancer. Breast Cancer Research. 23(1). 2–2. 30 indexed citations

Kelly, Tracy L., et al.. (2021). Manual scalp cooling in early-stage breast cancer case report: Value of caretaker training and patient experience to optimize efficacy and patient selection. SHILAP Revista de lepidopterología. 4. 100096–100096. 2 indexed citations

Kim, Isaac, Venkatesh Rajamanickam, Brady Bernard, et al.. (2021). A Case Series of Metastatic Metaplastic Breast Carcinoma Treated With Anti-PD-1 Therapy. Frontiers in Oncology. 11. 635237–635237. 14 indexed citations

Gatti‐Mays, Margaret E., Justin M. Balko, Sofia R. Gameiro, et al.. (2019). If we build it they will come: targeting the immune response to breast cancer. npj Breast Cancer. 5(1). 37–37. 140 indexed citations

Kim, Isaac, et al.. (2019). Immunotherapy in Triple-Negative Breast Cancer: Present and Future. Current Breast Cancer Reports. 11(4). 259–271. 24 indexed citations

Thomas, Alexandra, Eric D. Routh, Ashok Pullikuth, et al.. (2018). Tumor mutational burden is a determinant of immune-mediated survival in breast cancer. OncoImmunology. 7(10). e1490854–e1490854. 209 indexed citations

10.

Page, David B., Enyo Ablordeppey, Brian T. Wessman, et al.. (2018). Emergency department hyperoxia is associated with increased mortality in mechanically ventilated patients: a cohort study. Critical Care. 22(1). 9–9. 84 indexed citations

11.

Page, David B., Joanna Pucilowska, Neil L. Berinstein, & James E. Egan. (2018). Tumor infiltrating lymphocyte recruitment in patients with early stage breast cancer after intramammary IRX-2 cytokine immunotherapy.. Journal of Clinical Oncology. 36(5_suppl). 7–7. 1 indexed citations

12.

Page, David B., Hannah Y. Wen, Edi Brogi, et al.. (2017). Monosomy 17 in potentially curable HER2-amplified breast cancer: prognostic and predictive impact. Breast Cancer Research and Treatment. 167(2). 547–554. 16 indexed citations

13.

Mariotti, Veronica, David B. Page, Didier Hans, et al.. (2016). Assessing fracture risk in early stage breast cancer patients treated with aromatase-inhibitors: An enhanced screening approach incorporating trabecular bone score. Journal of bone oncology. 7. 32–37. 26 indexed citations

14.

Yuan, Jianda, Priti S. Hegde, Raphael Clynes, et al.. (2016). Novel technologies and emerging biomarkers for personalized cancer immunotherapy. Journal for ImmunoTherapy of Cancer. 4(1). 3–3. 162 indexed citations

15.

Naidoo, Jarushka, Bob T. Li, Katja Schindler, & David B. Page. (2016). What does the future hold for immunotherapy in cancer?. Annals of Translational Medicine. 4(9). 177–177. 22 indexed citations

16.

Page, David B., Tyler Hulett, Traci Hilton, et al.. (2016). Glimpse into the future: harnessing autophagy to promote anti-tumor immunity with the DRibbles vaccine. Journal for ImmunoTherapy of Cancer. 4(1). 25–25. 27 indexed citations

17.

Page, David B., John P. Donnelly, & Henry E. Wang. (2015). Community-, Healthcare-, and Hospital-Acquired Severe Sepsis Hospitalizations in the University HealthSystem Consortium. Critical Care Medicine. 43(9). 1945–1951. 99 indexed citations

18.

Naidoo, Jarushka, David B. Page, Bob T. Li, et al.. (2015). Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies. Annals of Oncology. 26(12). 2375–2391. 1186 indexed citations breakdown →

19.

Yuan, Jianda, Brian Ginsberg, David B. Page, et al.. (2011). CTLA-4 blockade increases antigen-specific CD8+ T cells in prevaccinated patients with melanoma: three cases. Cancer Immunology Immunotherapy. 60(8). 1137–1146. 71 indexed citations

20.

Page, David B., Frances M. Weaver, Diana J. Wilkie, & Tanya Simuni. (2009). A computerized survey of pain in Parkinson's disease patients: A pilot feasibility study. Parkinsonism & Related Disorders. 16(2). 139–141. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact